Skip to main content
Livermore
Livermore
ZHEN

ProShare Advisors LLC

SEC CIK
0001357955
Latest filing
Aug 11, 2026

AMPH holding history

Amphastar Pharmaceuticals, Inc. in every 13F filed by ProShare Advisors LLC, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.

AMPH overviewAll 13F holders of AMPHFull Q2 2026 holdings

Shares (Q1 2026)
0
Sold out in Q1 2026
Value
$0
% of portfolio
0.0%
Quarters held
20
Since Q1 2021
Holdings of AMPH by ProShare Advisors LLC, by quarter
QuarterSharesValue% of portfolioShare changeActionAll holders
Q1 20260$00.0%−9,083−100.0%Sold outHolders
Q4 20259,083$243.2K<0.1%+457+5.3%AddedHolders
Q3 20258,626$229.9K<0.1%−1,413−14.1%ReducedHolders
Q2 202510,039$230.5K<0.1%−1,038−9.4%ReducedHolders
Q1 202511,077$321.1K<0.1%−2,775−20.0%ReducedHolders
Q4 202413,852$514.3K<0.1%+2,958+27.2%AddedHolders
Q3 202410,894$528.7K<0.1%+2,054+23.2%AddedHolders
Q2 20248,840$353.6K<0.1%−2,133−19.4%ReducedHolders
Q1 202410,973$481.8K<0.1%+708+6.9%AddedHolders
Q4 202310,265$634.9K<0.1%+1,286+14.3%AddedHolders
Q3 20238,979$412.9K<0.1%−69−0.8%ReducedHolders
Q2 20239,048$520.0K<0.1%+161+1.8%AddedHolders
Q1 20238,887$333.3K<0.1%−1,136−11.3%ReducedHolders
Q4 202210,023$280.8K<0.1%+637+6.8%AddedHolders
Q3 20229,386$264.0K<0.1%+204+2.2%AddedHolders
Q2 20229,182$319.0K<0.1%−3,994−30.3%ReducedHolders
Q1 202213,176$473.0K<0.1%−2,803−17.5%ReducedHolders
Q4 202115,979$372.0K<0.1%+20+0.1%AddedHolders
Q3 202115,959$303.0K<0.1%−3,199−16.7%ReducedHolders
Q2 202119,158$386.0K<0.1%+1,768+10.2%AddedHolders
Q1 202117,390$319.0K<0.1%––Holders

Livermore's 13F data starts with Q1 2021, so Q1 2021 has no change from the previous quarter.